Total Payments
$127,832
2024 Payments
$7,001
Companies
22
Transactions
584
Medicare Patients
967
Medicare Billing
$256,994
Payment Breakdown by Category
Other$101,850 (79.7%)
Consulting$14,006 (11.0%)
Food & Beverage$6,204 (4.9%)
Travel$5,708 (4.5%)
Education$64.35 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101,850 | 54 | 79.7% |
| Consulting Fee | $14,006 | 3 | 11.0% |
| Food and Beverage | $6,204 | 478 | 4.9% |
| Travel and Lodging | $5,708 | 46 | 4.5% |
| Education | $64.35 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $52,879 | 160 | $0 (2020) |
| ABBVIE INC. | $41,772 | 170 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $16,206 | 43 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $5,318 | 9 | $0 (2018) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,946 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $4,192 | 9 | $0 (2019) |
| Lundbeck LLC | $555.86 | 43 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $507.22 | 33 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $402.81 | 40 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $197.28 | 10 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,001 | 22 | ABBVIE INC. ($7,001) |
| 2023 | $28,181 | 66 | AbbVie Inc. ($28,164) |
| 2022 | $321.19 | 41 | ABBVIE INC. ($185.44) |
| 2021 | $13,677 | 59 | Janssen Pharmaceuticals, Inc ($7,189) |
| 2020 | $15,150 | 49 | Allergan, Inc. ($14,995) |
| 2019 | $34,204 | 137 | Allergan Inc. ($24,585) |
| 2018 | $18,917 | 98 | Allergan Inc. ($13,067) |
| 2017 | $10,381 | 112 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($4,946) |
All Payment Transactions
584 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $8.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $33.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.23 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 272 | 1,191 | $215,330 | $68,344 |
| 2022 | 3 | 204 | 1,306 | $202,675 | $67,357 |
| 2021 | 3 | 211 | 1,113 | $157,077 | $55,025 |
| 2020 | 3 | 280 | 1,444 | $203,902 | $66,268 |
Total Patients
967
Total Services
5,054
Medicare Billing
$256,994
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 90 | 456 | $91,200 | $21,305 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 394 | $59,100 | $20,219 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 215 | $37,625 | $18,784 | 49.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 16 | 126 | $27,405 | $8,036 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 663 | $89,425 | $34,912 | 39.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 93 | 536 | $90,600 | $25,638 | 28.3% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 16 | 107 | $22,650 | $6,807 | 30.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 557 | $69,625 | $27,776 | 39.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 98 | 472 | $70,652 | $21,880 | 31.0% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 11 | 84 | $16,800 | $5,369 | 32.0% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 109 | 585 | $87,602 | $28,826 | 32.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 109 | 696 | $87,000 | $27,706 | 31.8% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 14 | 111 | $22,200 | $7,376 | 33.2% |
| 90833 | Psychotherapy, 30 minutes | Facility | 2020 | 23 | 24 | $3,600 | $1,235 | 34.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 25 | 28 | $3,500 | $1,125 | 32.1% |
About Dr. Peter Zafirides, MD
Dr. Peter Zafirides, MD is a Psychiatry healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699845388.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Zafirides, MD has received a total of $127,832 in payments from pharmaceutical and medical device companies, with $7,001 received in 2024. These payments were reported across 584 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($101,850).
As a Medicare-enrolled provider, Zafirides has provided services to 967 Medicare beneficiaries, totaling 5,054 services with total Medicare billing of $256,994. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Columbus, OH
- Active Since 11/09/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1699845388
Products in Payments
- VRAYLAR (Drug) $94,652
- SPRAVATO (Drug) $16,189
- INGREZZA (Drug) $5,318
- AUSTEDO (Drug) $3,629
- REXULTI (Drug) $906.57
- SD809-TD (Drug) $562.95
- Trintellix (Drug) $464.64
- Fanapt (Drug) $197.28
- TRINTELLIX (Drug) $176.40
- NUEDEXTA (Drug) $156.67
- VYVANSE (Drug) $84.55
- Evekeo (Drug) $80.28
- BRINTELLIX (Drug) $75.26
- MYDAYIS (Drug) $74.97
- LATUDA (Drug) $61.74
- WELLBUTRIN XL (Drug) $45.58
- Horizant (Drug) $35.05
- NEUROSTAR TMS THERAPY (Device) $28.43
- APLENZIN (Drug) $25.90
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $25.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbus
Fred Romeo, Md, MD
Psychiatry — Payments: $2.3M
Psychiatry $2.3M
Michael Saribalas
Psychiatry — Payments: $1.3M
Psychiatry $1.3M
Kevin Ware, Md, MD
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Benjamin Roy, M.d, M.D
Psychiatry — Payments: $102,125
Psychiatry $102,125
Barbara Gracious, M.d, M.D
Psychiatry — Payments: $58,986
Psychiatry $58,986
Dr. Pavan Dontineni, M.d, M.D
Psychiatry — Payments: $32,829
Psychiatry $32,829